Cargando…
PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells
BACKGROUND: Lymphatic metastasis, facilitated by lymphangiogenesis is a common occurrence in breast cancer, the molecular mechanisms remaining incompletely understood. We had earlier shown that cyclooxygenase (COX)-2 expression by human or murine breast cancer cells promoted lymphangiogenesis and ly...
Autores principales: | Nandi, Pinki, Girish, Gannareddy V., Majumder, Mousumi, Xin, Xiping, Tutunea-Fatan, Elena, Lala, Peeyush K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217626/ https://www.ncbi.nlm.nih.gov/pubmed/28056899 http://dx.doi.org/10.1186/s12885-016-3018-2 |
Ejemplares similares
-
The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis
por: Tutunea-Fatan, Elena, et al.
Publicado: (2015) -
Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions
por: Majumder, Mousumi, et al.
Publicado: (2014) -
Co-Expression of α9β1 Integrin and VEGF-D Confers Lymphatic Metastatic Ability to a Human Breast Cancer Cell Line MDA-MB-468LN
por: Majumder, Mousumi, et al.
Publicado: (2012) -
EP4 as a Therapeutic Target for Aggressive Human Breast Cancer
por: Majumder, Mousumi, et al.
Publicado: (2018) -
Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis
por: De Paz Linares, Guillermo Antonio, et al.
Publicado: (2021)